These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 5439890)

  • 21. [Clinical and internal medicine therapy of biliary tract diseases].
    Schentke KU
    Z Gesamte Inn Med; 1980 Aug; 35(16):642-6. PubMed ID: 7467579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholelithiasis in rabbits: effects of diet upon formation and dissolution of gallstones.
    Borgman RF; Haselden FH
    Am J Vet Res; 1968 Jun; 29(6):1287-92. PubMed ID: 5656790
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prophylaxis and therapy of cholelithiasis].
    Braunsteiner H
    Landarzt; 1968 Feb; 44(6):295. PubMed ID: 5716866
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical and therapeutic evaluation of a new antilipemic substance].
    de Aguiar Magano L
    Arch Sci Med (Torino); 1980; 137(1):131-9. PubMed ID: 7458646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mouse as a model for evaluation of hypotriglyceridemic drugs effects of nicotinic acid, clofibrate and ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate on plasma lipoproteins.
    Gustafsson K; Kiessling H
    Z Versuchstierkd; 1982; 24(5-6):271-7. PubMed ID: 7170839
    [No Abstract]   [Full Text] [Related]  

  • 26. [The pathogenesis of biliary stone formation and its prevention in biliary tract diseases].
    Vakhrushev IaM; Khokhlacheva NA
    Ter Arkh; 1999; 71(2):44-8. PubMed ID: 10222553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Removal of cholesterol calculi by medication: possibilities and problems.
    Pollak OJ
    Del Med J; 1982 Apr; 54(4):238-40. PubMed ID: 7084528
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cholelithiasis. New developments in prevention].
    Galkin VA
    Ter Arkh; 1996; 68(1):6-8. PubMed ID: 8644037
    [No Abstract]   [Full Text] [Related]  

  • 29. [Study on the cholelitholytic effect and safety of the preparation of Chinese medicine compound].
    Yang H; Guo YN; Yi H; Yang ZX; Zhang QW; Zhang YX
    Zhongguo Zhong Yao Za Zhi; 2006 May; 31(10):839-42. PubMed ID: 17048671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dietetic therapy of obesity. Preliminary considerations on the combined therapy with ursodeoxycholic acid in the prevention of cholesterol lithiasis].
    De Filippo E; Ferrieri A; Marra M; Contaldo F
    Minerva Med; 1993 May; 84(5):269-74. PubMed ID: 8316346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Basis for the use of a new galena-based substance from plants for prevention and treatment of cholelithic disease].
    Bogdarin IuA; Bundin DV
    Eksp Klin Gastroenterol; 2003; (3):47-9, 117. PubMed ID: 14556547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cholecystolithiasis and choledocholithiasis cured by methyl tert butyl ether (MTBE) combined with EST].
    Taya N; Moriya M; Fujii T; Nishimura K; Takahashi A; Matsumoto A; Namiki M
    Hokkaido Igaku Zasshi; 1993 Jan; 68(1):121-5. PubMed ID: 8444400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary garlic and onion reduce the incidence of atherogenic diet-induced cholesterol gallstones in experimental mice.
    Vidyashankar S; Sambaiah K; Srinivasan K
    Br J Nutr; 2009 Jun; 101(11):1621-9. PubMed ID: 18983715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissolution of cholesterol gallstones in mice by the oral administration of a fatty acid bile acid conjugate.
    Gilat T; Leikin-Frenkel A; Goldiner I; Halpern Z; Konikoff FM
    Hepatology; 2002 Mar; 35(3):597-600. PubMed ID: 11870372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholelithiasis, oxidative stress and melatonin.
    Reiter RJ; Tan DX; Karbownik M
    J Pineal Res; 2001 Mar; 30(2):127-8. PubMed ID: 11270480
    [No Abstract]   [Full Text] [Related]  

  • 36. Protection by clofibrate against acetaminophen hepatotoxicity in male CD-1 mice is associated with an early increase in biliary concentration of acetaminophen-glutathione adducts.
    Manautou JE; Tveit A; Hoivik DJ; Khairallah EA; Cohen SD
    Toxicol Appl Pharmacol; 1996 Sep; 140(1):30-8. PubMed ID: 8806867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Is there any alternative to cholecystolithiasis surgery?].
    Saĭfutdinov RG; Ryzhkova OV
    Eksp Klin Gastroenterol; 2005; (5):100-4, 125. PubMed ID: 16518924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [An animal model for testing hypoglycemic and hypolipidemic drugs].
    Liu J; Shen ZF; Liu HF; Ye F; Xie MZ
    Yao Xue Xue Bao; 1994; 29(5):387-9. PubMed ID: 7976355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular cloning and regulation of expression of two novel mouse CYP4F genes: expression in peroxisome proliferator-activated receptor alpha-deficient mice upon lipopolysaccharide and clofibrate challenges.
    Cui X; Kawashima H; Barclay TB; Peters JM; Gonzalez FJ; Morgan ET; Strobel HW
    J Pharmacol Exp Ther; 2001 Feb; 296(2):542-50. PubMed ID: 11160642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)].
    Sterner W; Chibanguza G; Metz G
    Arzneimittelforschung; 1980; 30(11b):2038-41. PubMed ID: 7194056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.